Pascal Rippert

Learn More
OBJECTIVE To validate a useful version of the Motor Function Measure (MFM) in children with neuromuscular diseases aged <7 years old. DESIGN Two prospective cohort studies that documented the MFM completion of children aged between 2 and 7 years old. SETTING French-speaking rehabilitation departments from France, Belgium, and Switzerland. PARTICIPANTS(More)
Steroids are nowadays routinely used as a long-term treatment in Duchenne muscular dystrophy (DMD). Their effects on body composition were assessed using dual X-ray absorptiometry. The study followed over 2 years 29 genetically confirmed DMD patients: 21 in the steroid-treated group and 8 in the steroid-naïve group. After 2 years of steroid treatment, the(More)
BACKGROUND Postoperative delirium is common in the elderly and is associated with a significant increase in mortality, complications, length of hospital stay and admission in long care facility. Although several interventions have proved their effectiveness to prevent it, the Cochrane advises an assessment of multifaceted intervention using rigorous(More)
OBJECTIVE To develop a classification for neuromuscular disease patients in each of the three motor function domains (D1: standing and transfers; D2: axial and proximal function; D3: distal function). MATERIALS AND METHODS A draft classification was developed by a study group and then improved by qualitative validation studies (according to the Delphi(More)
  • 1